(non) Hodgkin's disease hematopoietische malignicies Kahler's diseases leukemia
Conditions
Interventions
The intervention group receives an individually adjusted physical exercise
program of one hour duration which will be administered two times per week
during the 6 weeks prior to the HSCT. The progra
the maximum amount of weight one can lift in a
single repetition for a given exercise). By using a lighter test load and a
small number of repetitions the 1 RM can be calculated based on existing ta
Sponsors
Universitair Medisch Centrum Sint Radboud
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Diagnosed with acute or chronic leukemia, Hodgkin*s Lymphoma, non-Hodgkins*s Lymphoma or Multiple Myeloma; - Scheduled to undergo an allogenic or autologous HSCT; - No cardiovascular contra-indication to engage in physical activity programs as checked by the Physical Activities Readiness Questionnaire (PAR-Q) (Thomas et al 1992), and/or no other physical limitations for physical exercise programs; - Sufficient knowledge of the Dutch language; - Approval to participate in the study by the treating physician, and - Being aged in the age range 18 years through 65 years
Exclusion criteria
Exclusion criteria: Cardiovascular or other contra-indications (e.g. rheumatic disease) for participating in a physical exercise program. Decisions to exclude potential participants will be made based on the results of the Physical Activities Readiness Questionnaire (PAR-Q) and after consultation with the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is self-perceived physical functioning (subscale of SF-36 questionnaire). | — |
Secondary
| Measure | Time frame |
|---|---|
| Global perceived recovery (7-points Likert-scale), tiredness (CIS-20 questionnaire), Quality of life (SF-36 questionnaire), incidence of oral and lung infections (patient files), length of hospital stay, V02 max (submaximal bicycle test), muscle strength of large muscle groups (dynamometer), and lymphocyte count. | — |
Countries
Netherlands
Outcome results
None listed